Nitrosation and nitration of 2-amino-3-methylimidazo[4,5-f]quinoline by reactive nitrogen oxygen species

Chemical Research in Toxicology

Volumn 15, Issue 8, 2002, Pages 1059-1068

  Lakshmi, Vijaya M ^a   Hsu, Fong Fu ^b   Zenser, Terry V ^a,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 3 METHYLIMIDAZO[4,5 F]QUINOLINE; DIETHYLAMINE; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; QUINOLINE DERIVATIVE; REACTIVE OXYGEN METABOLITE; 2 AMINO 3 METHYLIMIDAZO(4,5 F)QUINOLINE; 2-AMINO-3-METHYLIMIDAZO(4,5-F)QUINOLINE; CARCINOGEN; NITRATE; REACTIVE NITROGEN SPECIES;

ANIMAL CELL; ARTICLE; CHEMICAL REACTION; COLON CANCER; CONTROLLED STUDY; COOKING; DNA ADDUCT; DNA BINDING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFLAMMATION; MASS SPECTROMETRY; MOUSE; NITRATION; NITROSATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE; ANIMAL; CELL LINE; ELECTROSPRAY MASS SPECTROMETRY; MACROPHAGE; METABOLISM;

ANIMAL; CARCINOGENS; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; MACROPHAGES; MICE; NITRATES; NITROSATION; QUINOLINES; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; ANIMALS;

ANIMALIA;

EID: 0036667455     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx020008h     Document Type: Article

References (67)

1. Nutrition and dietary carcinogens
2. Multipotential carcinogenicity of the fried food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline in rats
3. Demonstration of carcinogenicity in F344 rats of 2-amino-3-methylimidazo[4,5-f]quinoline, from broiled sardine, fried beef and beef extract
4. Carcinogenicity of 2-amino-3-methylimidazo [4,5-f]quinoline in nonhuman primates: Induction of tumors in three macaques
5. Heterocyclic-amine mutagens/carcinogens in foods
6. Formation of mutagenic/carcinogenic heterocyclic amines in dryheated model systems, meats, and meat drippings
7. Intra- and interindividual variability in systemic exposure in humans to 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline and 2-amino-l-methyl-6-phenylimidazo[4,5-b]pyridine, carcinogens present in cooked beef
8. Uses of nitrite and hypochlorite treatments in determination of the contributions of IQ-type and non-IQ type heterocyclic amines to the mutagenicities in crude pyrolized materials
9. Intake of fat, meat, and fiber in relation to risk of colon cancer in men
10. The ability of two cooked food mutagens to induce aberrant crypt foci in mice
11. Activation of heterocyclic aromatic amines by rat and human liver microsomes and by purified rat and human cytochrome P450 1A2
12. CYP1A2-catalyzed conversion of dietary heterocyclic amines to their proximate carcinogens is their major route of metabolism in humans
13. Glucuronidation of N-hydroxy heterocyclic amines by human and rat liver microsomes
14. N- and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells
15. Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon
16. Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s)
17. 2 atoms of guanine
18. DNA adducts of heterocyclic amine food mutagens: Implications for mutagenesis and carcinogenesis
19. A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer
20. Meat consumption, genetic susceptibility, and colon cancer risk: A United States multicenter case-control study
21. DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in colon, bladder, and kidney of congenic mice differing in Ah responsiveness and N-acetyltransferase genotype
22. DNA adduct formation of the food-derived mutagen 2-amino-3-methylimidazo[4,5-f]quinoline in nonhuman primates undergoing carcinogen bioassay
23. Prostaglandin H synthase dependent mutagenic activation of heterocyclic aromatic amines of the IQ-type
24. Prostaglandin hydroperoxidase-dependent activation of heterocyclic aromatic amines
25. Prostaglandin H synthase-catalyzed activation of benzidine: A model to assess pharmacologic intervention of the initiation of chemical carcinogenesis
26. Prostaglandin H synthase-dependent formation of the direct-acting mutagen 2-nitro-3-methylimidazo[4,5-f]quinoline (nitro-IQ) from IQ
27. Pathways of heterocyclic amine activation in the breast: DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) formed by peroxidases and in human mammary epithelial cells and fibroblasts
28. Bioactivation of the food mutagen 2-amino-3-methyl-imidazo[4,5-f]quinoline (IQ) by prostaglandin-H synthase and by monooxygenases: DNA adduct analysis
29. Peroxygenase metabolism of N-acetylbenzidine by prostaglandin H synthase
30. Microsomal activation of 2-amino-3-methylimidazo [4,5-f]quinoline, a pyrolysate of sardine and beef extracts, to a mutagenic intermediate
31. The primary aromatic amines: Their biological properties and structure-activity relationships
32. Inflammatory bowel disease: Etiology and pathogenesis
33. Twenty years colonoscopic surveillance of patients with ulcerative colitis. Detection of dysplasia and malignant transformation
34. A prospective study of the epidemiology of colitis and colon cancer in cotton-top tamarins (Saguinus oedipus)
35. High prevalence of colorectal cancer in HLA-B27 transgenic F344 rats with chronic inflammatory bowel disease
36. Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites: Implications in inflammation
37. Damage to DNA by reactive oxygen and nitrogen species: Role in inflammatory disease and progression to cancer
38. Chronic inflammation, mutation, and cancer
39. Nitric oxide modulates epithelial permeability in the feline small intestine
40. Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease
41. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease
42. Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer
43. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: A cancer-prone chronic inflammatory disease
44. Reactive nitrogen oxygen species metabolize N-acetylbenzidine
45. Oxidative chemistry of peroxynitrite
46. Synthesis and tritium labeling of the food mutagens IQ and methyl-IQ
47. The role of acetylation in benzidine metabolism and DNA adduct formation in dog and rat liver
48. 15N] nitrate in biological fluids
49. Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid
50. The micro-environment of inflammation or Metchnikoff revisited
51. β-lactamase activity in human pus
52. Double-stranded RNA-induced inducible nitric-oxide synthase expression and interleukin-1 release by murine macrophages requires NF-B activation
53. Mutagenicity and in vitro covalent DNA binding of 2-hydroxyamino-3-methylimidazolo[4,5-f]quinoline
54. Determination of the enzymes responsible for activation of the heterocyclic amine 2-amino-3-methylimidazo[4,5-f]quinoline in the human breast
55. Determination of selectivity of reactive nitrogen oxide species for various substrates
56. DNA adduct formation of the food carcinogen 2-amino-3-methylimidazo [4,5-f]quinoline (IQ) in liver, kidney and colo-rectum of rats
57. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite
58. Nitrating reactive nitric oxygen species transform acetaminophen to 3-nitro-acetaminophen
59. Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyneal and bladder cancer and contribution to cancer of known exposures to NOC
60. The physical properties of nitric oxide
61. Apparent differential sensitivity of nitric oxide synthase to feedback inhibition (by nitric oxide) in cells versus extracts
62. 2-Amino-3-methylimidazo[4,5-f]quinoline inhibits nitric oxide production in lipopolysaccharide-stimulated RAW 264.7 cells by blocking p38 kinase activation
63. Inducible nitric oxide synthase activity and expression in a human colonic epithelial cell line HT-29
64. iNOS upregulation mediates oxidant-induced disruption of F-actin and barrier of intestinal monolayers